Anixa Biosciences Inc Contracts & Agreements

55 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Joint Development and Option Agreement, dated May 3, 2024, between the Company and The Cleveland Clinic Foundation. (Certain information has been redacted in the marked portions...
Development Agreements
Anixa Biosciences Inc
2024
Amendment to Exclusive License Agreement between the Company and The Cleveland Clinic Foundation
License Agreements
Anixa Biosciences Inc
2024
Amendment No. 1 to Exclusive License Agreement between The Cleveland Clinic Foundation and Anixa Biosciences, Inc. (Certain information has been redacted in the marked portions of...
License Agreements
Anixa Biosciences Inc
2022
Form of Warrant issued to Acorn Management Partners LLC
Warrant Agreements
Anixa Biosciences Inc
Biotechnology
DE
2022
Amended and Restated Collaboration Agreement, dated November 1, 2021, between Certainty Therapeutics, Inc. and H. Lee Moffitt Cancer Center and Research Institute, Inc
Collaboration Agreements
Anixa Biosciences Inc
2022
Assignment Agreement dated May 1, 2021, between the Company, OntoChem GmbH and MolGenie GmbH
Assignment Agreements
Anixa Biosciences Inc
2021
Amendment 2 to the Collaboration Agreement between the Company and MolGenie GmbH. (Certain information has been redacted in the marked portions of the exhibit.)
Collaboration Agreements
Anixa Biosciences Inc
2021
Amended and Restated Underwriting Agreement, dated March 22, 2021, between Anixa Biosciences, Inc. and H.C. Wainwright & Co., LLC
Underwriting Agreements
Anixa Biosciences Inc
Biotechnology
NY
2021
Form of Underwriter Warrants
Anixa Biosciences Inc
2021
Amendment to License Agreement between Certainty Therapeutics, Inc. and The Wistar Institute of Anatomy and Biology. (Certain information has been redacted in the marked portions...
License Agreements
Anixa Biosciences Inc
2021
Joint Development and Option Agreement, dated January 26, 2021, between the Company and The Cleveland Clinic Foundation. (Certain information has been redacted in the marked...
Development Agreements
Anixa Biosciences Inc
Biotechnology
2021
Form of Warrant issued to Acorn Management Partners LLC
Warrant Agreements
Anixa Biosciences Inc
2021
Amendment 2 to the Collaboration Agreement between Certainty Therapeutics, Inc. and H. Lee Moffitt Cancer Center and Research Institute, Inc. (.) (Certain information has been...
Collaboration Agreements
Anixa Biosciences Inc
Biotechnology
2021
Amendement to Collaboration Agreement between the Company and OntoChem GmbH
Collaboration Agreements
Anixa Biosciences Inc
Biotechnology
DE
2021
Exclusive License Agreement, dated October 20, 2020, between the Company and The Cleveland Clinic Foundation. (.) (Certain information has been redacted in the marked portions of...
License Agreements
Anixa Biosciences Inc
2021
Redactions with respect to certain portions hereof denoted with *** COLLABORATION AGREEMENT
Collaboration Agreements
Anixa Biosciences Inc
Biotechnology
DE
2020
Redactions with respect to certain portions hereof denoted with “***” EXCLUSIVE LICENSE AGREEMENT between THE CLEVELAND CLINIC FOUNDATION and ANIXA BIOSCIENCES, INC. dated as...
License Agreements
Anixa Biosciences Inc
Biotechnology
OH
2019
AMENDMENT 1 TO THE COLLABORATION AGREEMENT BETWEEN CERTAINTY THERAPEUTICS, INC. AND H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
Collaboration Agreements
Anixa Biosciences Inc
2019
ITUS CORPORATION Common Stock (par value $0.01 per share) At Market Issuance Sales Agreement March 27, 2018 B. Riley FBR, Inc. 299 Park Avenue, 7th Floor New York, NY, 10171
Stock Agreements
Anixa Biosciences Inc
Biotechnology
NY
2018
Confidential Treatment Requested by ITUS Corporation, IRS Employer Identification No. 11 ###-###-#### ***CONFIDENTIAL TREATMENT REQUESTED***
Anixa Biosciences Inc
2018
Confidential Treatment Requested by ITUS Corporation, IRS Employer Identification No. 11 ###-###-#### ***CONFIDENTIAL TREATMENT REQUESTED***
Anixa Biosciences Inc
2018
ITUS CORPORATION Common Stock (par value $0.01 per share) At Market Issuance Sales Agreement
Stock Agreements
Anixa Biosciences Inc
2017
ITUS CORPORATION Common Stock (par value $0.01 per share) At Market Issuance Sales Agreement
Stock Agreements
Anixa Biosciences Inc
Biotechnology
VA
2017
PLACEMENT AGENCY AGREEMENT
Agency Agreements
Anixa Biosciences Inc
2017
DEALER-MANAGER AGREEMENT
Anixa Biosciences Inc
Biotechnology
NY
2017
Warrant to Purchase 500,000 Shares ITUS CORPORATION COMMON STOCK PURCHASE WARRANT
Stock Agreements
Anixa Biosciences Inc
Biotechnology
NY
2016
LETTER AGREEMENT
Anixa Biosciences Inc
2016
ITUS CORPORATION 12% Secured Debenture Due November 11, 2017
Debenture Agreements
Anixa Biosciences Inc
2016
ITUS CORPORATION Common Stock (par value $0.01 per share) At Market Issuance Sales Agreement
Stock Agreements
Anixa Biosciences Inc
2015
SETTLEMENT AGREEMENT
Settlement Agreements
Anixa Biosciences Inc
Biotechnology
CA
2015
PATENT ASSIGNMENT AGREEMENT
Assignment Agreements
Anixa Biosciences Inc
2015
EMPLOYMENT AGREEMENT
Employment Agreements
Anixa Biosciences Inc
Biotechnology
CA
2014
TERMINATION AGREEMENT
Termination Agreements
Anixa Biosciences Inc
Biotechnology
NY
2014
DEBT CONVERSION AGREEMENT
Anixa Biosciences Inc
Biotechnology
NY
2014
Warrant to Purchase 9,249,472 Shares ITUS CORPORATION COMMON STOCK PURCHASE WARRANT
Stock Agreements
Anixa Biosciences Inc
2014
EXHIBIT 4.1
Anixa Biosciences Inc
2014
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Anixa Biosciences Inc
Biotechnology
NY
2014
EXHIBIT 10.1 EXCLUSIVE LICENSE AGREEMENT
License Agreements
Anixa Biosciences Inc
2011
EXHIBIT 10.2 LICENSE AGREEMENT
License Agreements
Anixa Biosciences Inc
Biotechnology
CA
2011
AMENDMENT NO. 1 TO THE COPYTELE, INC. 2010 SHARE INCENTIVE PLAN
Bonus & Incentive Agreements
Anixa Biosciences Inc
2011
[COPYTELE, INC. LETTERHEAD]
Anixa Biosciences Inc
Biotechnology
2011
_____________________________________________
Anixa Biosciences Inc
Biotechnology
2011
Warrant No. ___Expiration Date: February 7, 2016 Warrant to Purchase _____________ Shares
Warrant Agreements
Anixa Biosciences Inc
2011
Warrant No. ___Expiration Date: February 7, 2016 Warrant to Purchase ______________ Shares
Warrant Agreements
Anixa Biosciences Inc
Biotechnology
NY
2011
Exhibit 10.21 [COPYTELE, INC. LETTERHEAD]
Anixa Biosciences Inc
2010
Exhibit 10.22 [COPYTELE, INC. LETTERHEAD]
Anixa Biosciences Inc
Biotechnology
2010
COPYTELE, INC. 2010 SHARE INCENTIVE PLAN
Bonus & Incentive Agreements
Anixa Biosciences Inc
2010
COPYTELE, INC. 2010 SHARE INCENTIVE PLAN STOCK AWARD AGREEMENT
Bonus & Incentive Agreements
Anixa Biosciences Inc
Biotechnology
NY
2010
Amendment No. 6 to the CopyTele, Inc. 2003 Share Incentive Plan Amended by the Companys Board of Directors on July 15, 2010
Bonus & Incentive Agreements
Anixa Biosciences Inc
2010
AMENDMENT OF OPTION AGREEMENTS
Anixa Biosciences Inc
2010
AMENDMENT OF OPTION AGREEMENTS
Anixa Biosciences Inc
2010
Exhibit 10.21 [COPYTELE, INC. LETTERHEAD]
Anixa Biosciences Inc
Biotechnology
2010
Exhibit 10.22 [COPYTELE, INC. LETTERHEAD]
Anixa Biosciences Inc
2010
COMMONSTOCK PURCHASE WARRANT THE SECURITIES REPRESENTED BY THIS CERTIFICATE, THE COMMON STOCK ISSUABLE UPON EXERCISE HEREOF, AND ANY INTEREST THEREIN MAY NOT BE OFFERED OR SOLD...
Warrant Agreements
Anixa Biosciences Inc
Biotechnology
2010
COMMONSTOCK PURCHASE WARRANT THE SECURITIES REPRESENTED BY THIS CERTIFICATE, THE COMMON STOCK ISSUABLE UPON EXERCISE HEREOF, AND ANY INTEREST THEREIN MAY NOT BE OFFERED OR SOLD...
Warrant Agreements
Anixa Biosciences Inc
Biotechnology
2010